Pronova BioPharma Announces Ruling by the District Court of Rome, Italy

LYSAKER, NORWAY--(Marketwire - August 20, 2008) - Pronova BioPharma ASA (OSE: PRON.OL) (“Pronova BioPharma” or the “company”) announces that the District Court of Rome, Italy, has decided not to uphold Pronova BioPharma’s motion for a preliminary injunction against Chiesi Farmaceutici SpA (“Chiesi Farmaceutici”). Written arguments of the court’s ruling have not yet been made available, and consequently the company is not in a position to comment on the contents of the ruling. The company believes the ruling will have no commercial impact given the continued strong growth in end-user sales and excess demand for the Active Pharmaceutical Ingredient on a global basis.

MORE ON THIS TOPIC